| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 5,218,000 | 4,901,000 | 5,314,000 | 4,981,000 | | Cost of Revenue | 2,559,000 | 2,461,000 | 2,826,000 | 2,508,000 | | | Gross Profit | 2,659,000 | 2,440,000 | 2,488,000 | 2,473,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,278,000 | 1,350,000 | 1,264,000 | 1,221,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 679,000 | 666,000 | 645,000 | 594,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 702,000 | 424,000 | 579,000 | 658,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 60,000 | 13,000 | 43,000 | 38,000 | | Earnings Before Interest And Taxes | 762,000 | 437,000 | 622,000 | 696,000 | | Interest Expense | 102,000 | 101,000 | 112,000 | 103,000 | | Income Before Tax | 660,000 | 336,000 | 510,000 | 593,000 | | Income Tax Expense | 242,000 | 124,000 | 152,000 | 195,000 | | Minority Interest | (22,000) |
-
| (32,000) | (35,000) | | | | Net Income From Continuing Ops | 396,000 | 212,000 | 326,000 | 363,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 6,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 396,000 | 212,000 | 332,000 | 363,000 | | Preferred Stock And Other Adjustments | 11,000 | (11,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $407,000 | $201,000 | $332,000 | $363,000 |
|
0.20% Nasdaq 
0.14%
Income Statement
